Clinical trial Recruiting at 30 sites Interventional Ages 5 and up

Treatment options for brain arteriovenous malformations

Official title: Treatment of Brain AVMs (TOBAS) Study: A Randomized Controlled Trial and Registry

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT02098252 · Data updated 2026-11-12

This study is testing different treatment options for people with brain arteriovenous malformations to see which ones work best in preventing serious problems like stroke or death over ten years.

Quick facts

Study typeInterventional
Ages5 Years and up
SexAll
Enrollment1000 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Drugs / interventionsradiation
Locations30 sites (Jacksonville, Florida and 29 other locations)
StatusRecruiting
StartedMay 2014
Main results expectedJanuary 2035
Study endsJanuary 2036
Registry record updatedAugust 15, 2024
Trial IDNCT02098252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study include any patient diagnosed with a brain AVM, whether it is ruptured or unruptured.

Probably not a fit

Patients with a hemorrhagic presentation requiring immediate surgical intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to determine the best management strategies for patients with brain arteriovenous malformations (AVMs), whether they are ruptured or unruptured. It will evaluate the effectiveness of medical management versus interventional therapies, including neurosurgery, radiation therapy, and embolization, in reducing the risk of death or debilitating stroke over a 10-year period. The study also seeks to assess if pre-surgical embolization can enhance the safety and efficacy of subsequent treatments. By analyzing long-term outcomes, the study hopes to provide clearer guidance on managing AVMs.

Why it matters

Potential benefit: If successful, this study could significantly reduce the risk of death and disability for patients with brain AVMs.

How similar studies have gone: Other studies have shown promise in managing brain AVMs with interventional therapies, but this study's comprehensive approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any patient with a brain AVM

Exclusion Criteria:

* Hemorrhagic presentation with mass effect requiring surgical management. In these cases, if a residual AVM is found after the initial surgery, the patient could then be a candidate for TOBAS.

Where it's running

  • Mayo Clinic in Jacksonville FL
    Jacksonville, Florida, United States
    Recruiting
  • Boston Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • University of New Mexico Health Sciences Center
    Albuquerque, New Mexico, United States
    Recruiting
  • Hospital Geral de Fortaleza
    Fortaleza, Brazil
    Recruiting
  • Universidade Federal de Sǎo Paulo
    São Paulo, Brazil
    Recruiting
  • University of Alberta Hospital
    Edmonton, Alberta, Canada
    Recruiting
Show 24 more locations
  • Klink, Ruby
    Montreal, Quebec, Canada
    Recruiting
  • Instituto de Neurocirugia Dr. A. Asenjo
    Santiago, Chile
    Recruiting
  • Universidad Autonoma de Bucaramanga
    Bucaramanga, Colombia
    Recruiting
  • CHRU de Brest (Brest University Hospital)
    Brest, Brittany Region, France
    Recruiting
  • Centre Hospit Régional Universitaire de Besançon
    Besançon, France
    Recruiting
  • Centre Hospitalier Universitaire de Bordeaux
    Bordeaux, France
    Recruiting
  • Centre Hospitalier Universitaire de Caen
    Caen, France
    Recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting
  • CHU Dijon Bourgogne
    Dijon, France
    Recruiting
  • Hôpital Bicêtre AP-HP
    Le Kremlin-Bicêtre, France
    Recruiting
  • CHU Limoges
    Limoges, France
    Recruiting
  • Centre Hospitalier Universitaire de Lyon
    Lyon, France
    Recruiting
  • Assistance Publique - Hôpitaux de Marseille
    Marseille, France
    Recruiting
  • Centre Hospitalier Universitaire de Montpellier
    Montpellier, France
    Recruiting
  • Centre Hospitalier Régional Universitaire de Nancy
    Nancy, France
    Recruiting
  • Centre Hospitalier Universitaire de Nantes
    Nantes, France
    Recruiting
  • Hôpital Universitaire Pitié-Salpêtrière
    Paris, France
    Recruiting
  • Fondation Ophtalmologique Rothschild
    Paris, France
    Recruiting
  • Centre Hospitalier Sainte-Anne
    Paris, France
    Recruiting
  • Centre Hospitalier Universitaire de Rennes
    Rennes, France
    Recruiting
  • Centre Hospitalier Universitaire Hôpitaux de Rouen
    Rouen, France
    Recruiting
  • Les Hôpitaux Universitaires de Strasbourg
    Strasbourg, France
    Recruiting
  • Centre Hospitalier Universitaire de Toulouse
    Toulouse, France
    Recruiting
  • Centre Hospitalier Régional Universitaire de Tours
    Tours, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.